These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 23639644)

  • 1. Surgical considerations in the treatment of gastric cancer.
    Blakely AM; Miner TJ
    Gastroenterol Clin North Am; 2013 Jun; 42(2):337-57. PubMed ID: 23639644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Level I evidence in support of perioperative chemotherapy for operable gastric cancer: sufficient for wide clinical use?
    Briasoulis E; Fatouros M; Roukos DH
    Ann Surg Oncol; 2007 Oct; 14(10):2691-5. PubMed ID: 17653806
    [No Abstract]   [Full Text] [Related]  

  • 3. Current trends in the surgical treatment of esophageal and cardia adenocarcinoma.
    Peracchia A; Bonavina L; Via A; Incarbone R
    J Exp Clin Cancer Res; 1999 Sep; 18(3):289-94. PubMed ID: 10606171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized Phase II trial of systemic chemotherapy with and without trastuzumab followed by surgery in HER2-positive advanced gastric or esophagogastric junction adenocarcinoma with extensive lymph node metastasis: Japan Clinical Oncology Group study JCOG1301 (Trigger Study).
    Kataoka K; Tokunaga M; Mizusawa J; Machida N; Katayama H; Shitara K; Tomita T; Nakamura K; Boku N; Sano T; Terashima M; Sasako M;
    Jpn J Clin Oncol; 2015 Nov; 45(11):1082-6. PubMed ID: 26355164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Neoadjuvant therapy in the upper gastro-intestinal tract. Gastric cancer from a surgical viewpoint].
    Ott K; Lordick F
    Chirurg; 2009 Nov; 80(11):1028-34. PubMed ID: 19756431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NeoFLOT: Multicenter phase II study of perioperative chemotherapy in resectable adenocarcinoma of the gastroesophageal junction or gastric adenocarcinoma-Very good response predominantly in patients with intestinal type tumors.
    Schulz C; Kullmann F; Kunzmann V; Fuchs M; Geissler M; Vehling-Kaiser U; Stauder H; Wein A; Al-Batran SE; Kubin T; Schäfer C; Stintzing S; Giessen C; Modest DP; Ridwelski K; Heinemann V
    Int J Cancer; 2015 Aug; 137(3):678-85. PubMed ID: 25530271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Current S3 guidelines on surgical treatment of gastric carcinoma].
    Meyer HJ; Hölscher AH; Lordick F; Messmann H; Mönig S; Schumacher C; Stahl M; Wilke H; Möhler M
    Chirurg; 2012 Jan; 83(1):31-7. PubMed ID: 22127381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neoadjuvant chemotherapy compared with surgery alone for locally advanced cancer of the stomach and cardia: European Organisation for Research and Treatment of Cancer randomized trial 40954.
    Schuhmacher C; Gretschel S; Lordick F; Reichardt P; Hohenberger W; Eisenberger CF; Haag C; Mauer ME; Hasan B; Welch J; Ott K; Hoelscher A; Schneider PM; Bechstein W; Wilke H; Lutz MP; Nordlinger B; Van Cutsem E; Siewert JR; Schlag PM
    J Clin Oncol; 2010 Dec; 28(35):5210-8. PubMed ID: 21060024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Modern diagnostics and stage-oriented surgery: therapy of adenocarcinoma of the esophagogastric junction].
    Hölscher AH; Fetzner UK
    Chirurg; 2012 Aug; 83(8):702-8, 710-1. PubMed ID: 22878576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant (cisplatin, etoposide, and 5-fluorouracil) chemotherapy after curative resection of gastric adenocarcinomas involving the esophagogastric junction.
    Ryoo BY; Kang YK; Im YH; Kim YJ; Kim BS; Kim TY; Jung SH; Park JH; Baek HJ; Kim YC; Shim YM; Kim CM; Zo JI
    Am J Clin Oncol; 1999 Jun; 22(3):253-7. PubMed ID: 10362331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Neoadjuvant chemoradiotherapy combined with surgery versus direct surgery in the treatment of Siewert type II and III adenocarcinomas of the esophagogastric junction: long-term prognostic analysis of a prospective randomized controlled trial].
    Tian Y; Wang Q; Wang J; Qiao XY; Zhang J; Lin YC; Li Y; Fan LQ; Yang PG; Zhao Q
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):128-137. PubMed ID: 33508918
    [No Abstract]   [Full Text] [Related]  

  • 12. Surgery in oesophago-gastric cancer with metastatic disease: Treatment, prognosis and preoperative patient selection.
    Schmidt T; Alldinger I; Blank S; Klose J; Springfeld C; Dreikhausen L; Weichert W; Grenacher L; Bruckner T; Lordick F; Ulrich A; Büchler MW; Ott K
    Eur J Surg Oncol; 2015 Oct; 41(10):1340-7. PubMed ID: 26213358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of perioperative chemotherapy for patients with an adenocarcinoma of the gastroesophageal junction: A propensity score matched analysis.
    Parry K; van Rossum PS; Haj Mohammad N; Ruurda JP; van Hillegersberg R
    Eur J Surg Oncol; 2017 Jan; 43(1):226-233. PubMed ID: 27424786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of Different Neoadjuvant Chemotherapy Regimens on Response, Prognosis, and Complication Rate in Patients with Esophagogastric Adenocarcinoma.
    Springfeld C; Wiecha C; Kunzmann R; Heger U; Weichert W; Langer R; Stange A; Blank S; Sisic L; Schmidt T; Lordick F; Jäger D; Grenacher L; Bruckner T; Büchler MW; Ott K
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S905-14. PubMed ID: 26001861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful downstaging by S-1-based chemotherapy followed by surgical resections for gastric carcinoma with extensive distant lymph node metastasis - report of two cases and a review of cases with surgical resection after downstaging by S-1-based chemotherapy.
    Yoshida I; Sakurai Y; Komori Y; Tonomura S; Masui T; Shoji M; Nakamura Y; Imazu H; Uyama I; Ochiai M
    Hepatogastroenterology; 2005; 52(63):978-84. PubMed ID: 15966245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapy in gastric cancer. From an oncological perspective].
    Wilke H; Stahl M
    Chirurg; 2009 Nov; 80(11):1023-7. PubMed ID: 19902288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Advanced gastric cancer curatively resected following combined neoadjuvant chemotherapy--report of a case].
    Koike N; Ohwada S; Ogawa T; Kawashima K; Takeyoshi I; Sato Y; Kamiyama H; Morishita Y
    Gan To Kagaku Ryoho; 1998 May; 25(6):919-23. PubMed ID: 9617332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results of a nation-wide retrospective study of lymphadenectomy for esophagogastric junction carcinoma.
    Yamashita H; Seto Y; Sano T; Makuuchi H; Ando N; Sasako M;
    Gastric Cancer; 2017 Mar; 20(Suppl 1):69-83. PubMed ID: 27796514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Who profits from neoadjuvant radiochemotherapy for locally advanced esophageal carcinoma?
    Elsaleh H; Farrell JJ; Crane CH
    J Gastroenterol Hepatol; 2009 May; 24(5):708-10. PubMed ID: 19646012
    [No Abstract]   [Full Text] [Related]  

  • 20. Expert opinion on management of gastric and gastro-oesophageal junction adenocarcinoma on behalf of the European Organisation for Research and Treatment of Cancer (EORTC)-gastrointestinal cancer group.
    Van Cutsem E; Van de Velde C; Roth A; Lordick F; Köhne CH; Cascinu S; Aapro M;
    Eur J Cancer; 2008 Jan; 44(2):182-94. PubMed ID: 18093827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.